Clinical trials
Emphysema or COPD clinical trials
Below are recruiting emphysema or copd clinical trials, each written for real people, not researchers. We’re tracking 425 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07780669RecruitingPhase 3
Study of a new drug for moderate to severe COPD in smokers
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
Doral, FloridaAges 40–80 - NCT07762157Recruiting
Home-based exercise program for lung recovery after COPD flare-ups
This study tests whether a supervised home-based exercise program, delivered via video calls, can help people recovering from a COPD flare-up feel stronger and breathe easier, compared with usual care. If you join, you'll have regular online sessions with a rehab team from home.
Hong KongAges 18 years+ - NCT07751705Recruiting
Using sound waves to collect lung mucus samples in COPD patients
This trial is testing whether a device that uses sound waves can help collect lung mucus samples more easily in people with COPD. It compares two groups: current smokers and ex-smokers, to see if the device works differently for them.
Hanover, Lower SaxonyAges 40 years+ - NCT07715617Recruiting
Creating a prediction score for lung transplant or death in Alpha-1 Antitrypsin Deficiency
This study is creating a simple scoring system to predict who with Alpha-1 Antitrypsin Deficiency-related emphysema might need a lung transplant or die from the disease. Your medical records from 2010–2025 will help build this tool, with no extra tests or visits required.
BronAges 18 years+ - NCT05053061Recruiting
Telerehabilitation program for people with COPD at home
This trial tests whether supervised rehab exercises delivered by phone/video (telerehabilitation) can help people living with COPD. You may be a fit if you’re an adult with COPD who hasn’t done pulmonary rehabilitation before and can use a smartphone.
IzmirAges 18 years+ - NCT07705737RecruitingPhase 2
Testing Rademikibart for asthma or COPD flare-ups
This trial tests an investigational drug called Rademikibart for people having a severe asthma or COPD flare-up that needs emergency care and steroids. The study aims to see if the drug can help control the flare-up faster and reduce the need for more treatment.
Miami, FloridaAges 18–85 - NCT07684820RecruitingPhase 2
A study of ExPD-101 for COPD with chronic bronchitis and frequent flare-ups
This study tests an experimental drug (ExPD-101) given daily as a pill for 52 weeks for people with COPD who have chronic bronchitis and frequent flare-ups. It compares the drug to a placebo (inactive pill) to see if it reduces flare-ups and improves symptoms.
Phoenix, ArizonaAges 40–85 - NCT07666854Recruiting
Home-based vs. in-person lung rehab for COPD patients in remote areas
This study compares remote (tele-pulmonary) rehab to in-person rehab for people with moderate-to-severe COPD who live far from medical centers. You join from home using a phone or computer, with guided exercises and support.
Tel AvivAges 40 years+ - NCT07668518RecruitingPhase 1/Phase 2
Study of KIT2014 for moderate to severe COPD
This trial tests a new medicine called KIT2014 in people with moderate to severe COPD. It aims to see if the drug is safe, tolerable, and helps improve breathing and COPD symptoms.
Charlestown, New South WalesAges 40–80 - NCT07665931Recruiting
Testing Simeox for severe COPD with lung hyperinflation
This trial tests if a device called Simeox can reduce trapped air in the lungs of people with severe COPD. It may help you breathe easier if you have pulmonary hyperinflation.
Codogno, LombardyAges 18 years+ - NCT07646587RecruitingPhase 2
Safety Study of WIN378 for Moderate-Severe COPD
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
Los Angeles, CaliforniaAges 40–80 - NCT07655011Recruiting
Exercise order in lung rehab for COPD patients
This trial tests if the order of exercises during pulmonary rehabilitation can improve muscle strength in people with COPD. It compares different exercise sequences to find the most effective approach.
ReimsAges 18 years+ - NCT06691399Recruiting
Mouth care to prevent pneumonia in ICU COPD patients
This study tests whether a special mouth-care routine can help prevent pneumonia (a serious lung infection) in people with COPD who are in the ICU and need breathing support. If you are in the ICU with a COPD flare-up and are using a noninvasive breathing mask or high-flow oxygen, you may be able to join.
AsyutAges 18 years+ - NCT07635446Recruiting
Relaxation techniques for COPD anxiety, sleep, and fatigue
This study tests whether two relaxation methods—Laura Mitchell's technique and Benson relaxation—can help people with COPD feel less anxious, sleep better, and have more energy. You would learn and practice these techniques over the course of the study.
Lahore, Punjab ProvinceAges 40–60 - NCT04890938Recruiting
Sputum-guided care to help manage COPD flare-ups
This trial tests a COPD care plan guided by what’s found in your mucus (sputum), along with comprehensive case management. It aims to reduce COPD flare-ups and improve day-to-day health for people with a history of frequent exacerbations.
Hamilton, OntarioAges 40 years+ - NCT07612878Recruiting
Registry tracking COPD patients starting dupilumab treatment
This is a registry—an observational study tracking patients with COPD (chronic lung disease) who are newly starting a medication called dupilumab. Researchers will follow your health outcomes to learn how well this treatment works in real-world practice.
Indianapolis, IndianaAges 40 years+ - NCT07605117Recruiting
Special Exercise Training for COPD Patients
This study tests a new type of exercise training called isoinertial training (using special equipment that adjusts resistance as you move) for people with moderate to severe COPD. The goal is to see if this training can help improve your breathing, strength, and ability to do daily activities.
Bogotá, Bogotá, DCAges 50–80 - NCT06703359Recruiting
A short walking test to predict survival in COPD
This study looks at how well a 6-minute stepper test (a simple exercise test) can predict survival in people with COPD. It aims to understand if this test can help doctors know more about a patient's future health.
RouenAges 18 years+ - NCT07602192Recruiting
Chest Imaging and Blood Tests to Distinguish Asthma From COPD
This study uses chest CT scans and blood tests to better tell asthma and COPD apart and predict which treatments will work best for you. The goal is to help doctors diagnose and treat these lung conditions more accurately.
Seoul, Dongjak-guAges 19 years+ - NCT03564236Recruiting
Nasal high-flow oxygen for COPD flare-ups in hospital
This trial tests whether a special type of oxygen delivered through the nose (high-flow nasal oxygen) helps people hospitalized for a COPD flare-up. It is likely meant for people with significant breathing problems and recent repeat flare-ups.
ArnhemAges Any age - NCT07590362Recruiting
Testing breathing readiness measures in ventilated COPD patients
This study compares two methods of measuring whether patients with COPD who are on breathing machines are ready to breathe on their own. The goal is to find the best way to predict which patients can successfully come off the ventilator.
Sohag, Sohag GovernorateAges 18 years+ - NCT07583849RecruitingPhase 3
Testing a new inhaled powder for COPD symptoms
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
Beijing, Beijing MunicipalityAges 40–80 - NCT06733662Recruiting
Motivational interviewing education for COPD patients
This study tests whether a special education program (using motivational interviewing) can help people with COPD stick to their treatment plan and take better care of themselves. It's for people who are stable and not in the middle of a flare-up.
KahramanmaraşAges 18 years+ - NCT07566195RecruitingPhase 3
Long-term Safety of Tozorakimab in COPD Patients
This study follows patients who previously took part in a tozorakimab trial to see how safe the drug is over time. Tozorakimab is an antibody treatment designed to reduce flare-ups (exacerbations) in people with COPD, a chronic lung disease.
Aix-en-ProvenceAges 18–99
Hear when a new Emphysema or COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for emphysema or copd?
- Yes. Clin2 currently lists 425 recruiting emphysema or copd studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a emphysema or copd trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a emphysema or copd trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.